Exelixis Data Release Upcoming; Options Activity Spiking
Why Investors Are Watching Athersys Ahead Of Stem Cell Data
Last Week's Biotech IPO Recap
Zogenix Received FDA Approval, Now What?
What Investors Are Watching For In Regulus Therapeutics' Next Data Release
Stocks That Battle Cancer Were The Best-Performing Biotechs In January
Baird Releases Comments After Vertex Earnings Call
Baird Remains Buyers Of Gilead Before Earnings Release
Two New Biotech IPOs Debut Friday, One Deal Delayed
What You Need To Know About The Spark Therapeutics IPO
4 More Biotech IPOs Going Public This Week
Another Reason MannKind Could Be Up (In 1 Tweet)
3 Biotech IPOs Debuting This Week
What Investors Are Watching Ahead of Zogenix's FDA Approval Decision
Why Nevro Is Trading 25% Higher
Catalysts To Watch For In RBC Capital's 2015 Top Small-Cap Biotechs
Deutsche Bank Loves These Small-Cap Biotech Stocks
Why Minerva Neurosciences Is Trading Higher
4 More Biotech Secondaries Traders Are Watching
5 Biotech Secondaries Traders Are Watching